Joint Mental Health Research and Innovation Day 2026

 

logos of sponsor organizations


Addictions: From Evidence to Action

Date and Time: Tuesday, Nov. 24, 2026, 8:30 am to 4 pm

This event is free to attend.

About this event: 

Please join us for the Joint Mental Health Research and Innovation Day (JMHRID), held in-person at the Best Western Plus Lamplighter Inn and Conference Centre in London, Ontario on Tuesday, Nov. 24, 2026 between 8:30 am to 4 pm (Eastern Standard Time).

This year’s theme is “Addictions: From Evidence to Action” and will feature a keynote speaker, oral and poster presentations and awards. 

Learning objectives:

At the end of the Joint Mental Health Research and Innovation Day, participants will be able to:

  • Identify and discuss innovative basic, clinical, and population-level mental health and addiction research being conducted locally
  • Demonstrate enhanced familiarity with research being conducted locally on the etiology, pathophysiology, prevention, intervention, service delivery, recovery and rehabilitation of mental disorders and addiction
  • Reflect upon diverse methodological approaches to conducting innovative and impactful research in mental health and addiction care
  • Consider the potential value inherent in academic, healthcare, community, advocacy, and policy partnerships in enhancing mental health and addiction care, research and service delivery
Agenda

8:30 to 9 am - Doors Open - Coffee/Tea and Continental Breakfast
•    Sign-in at Welcome Desk

9 to 9:45 am
Room: Crystal Ballroom

•    Indigenous Elder Opening - Leo Nicholas 
•    Land Acknowledgement

Welcome 

•    Dr. Arlene MacDougall – Director of Research, Department of Psychiatry, and Assistant Dean, Clinical Research Training, Schulich School of Medicine & Dentistry, Western University
•    Dr. Jeremy Burton – Interim Vice President, Research and Scientific Director, Lawson Research Institute, St. Joseph's Health Care London
•    Dr. Nicole Girotti– Director, Academics and Research Operations, London Health Sciences Centre
•    Dr. Patricia Hall – Chair, Department of Psychiatry, Schulich School of Medicine & Dentistry, Western University

9:45 to10:30 am
Room: Crystal Ballroom

Keynote Presentation
“Panic and Indifference – Drug Policy and Evidence in Canada and Where Clinicians and Researchers Best Fit”

Dr. Alex Caudarella, MDCM CCFP AM ABAM(d) - Chief Executive Officer, Canadian Centre on Substance Use and Addiction

Learning Objectives:
•    Discuss evidence for various treatments and supports recently discussed including mandatory care, low-barrier treatment, housing and contingency management
•    Identify strategic ways of advancing policy in interactions with policy makers
•    Describe the lens of a synthetic drug use era in increasingly hyperlocal issues

10:30 to 11 am
Room: Crystal Ballroom

Question and Answer Period on Topic of Addictions

Panel Members:

1.    Dr. Alex Caudarella – CEO Canadian Centre on Substance Use and Addiction
2.    Dr. Arash Dhaliwal – Psychiatrist, Assistant Professor, Department of Psychiatry, Western University
3.    Angie Hamilton – Executive Director and Co-Founder of Families for Addiction Recovery (FAR)
4.    Michelle Boissonneault – 519Pursuit

11 to 11:15 am – Break

11:15 am to 12:15 pm - Oral Presentations - Concurrent Session A 
Room: Regency A, B, C and Crystal Ballroom

12:15 to 1:30 pm - Lunch and Poster Session 
Room: Crystal Ballroom

1:30 to 2:30 pm - Oral Presentations - Concurrent Session B 
Rooms: Regency A, B, and C

2:45 to 3:45 pm - Oral Presentations - Concurrent Session C 
Rooms: Regency A, B, C and Crystal Ballroom

2:30 to 2:45 pm - Break

3:45 to 4 pm - Closing Remarks, Prizes, and Awards Presentation
Room: Crystal Ballroom    
•    Dr. Arlene MacDougall – Chair of the Joint Mental Health Research and Innovation Day Scientific Planning Committee

 

 

25 per cent of this program is dedicated to participant interaction.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University. You may claim a maximum of 4.25 hours (credits are automatically calculated). Each participant should claim only those hours of credit that they actually spent participating in the educational program.

Joint Mental Health Research and Innovation Day is co-hosted by the Department of Psychiatry, Schulich School of Medicine and Dentistry, Western University; Lawson Research Institute, St. Joseph’s Health Care London; and London Health Sciences Centre Research Institute. This program has received no commercial support. 


Agenda Sessions

Concurrent Session A

Concurrent Session A

Theme: Mental Health in Global Contexts (Room: Regency A)

11:15 to 11:35 am
Non-Pharmacological Interventions for Severe Mental Illness in Low- and Middle-Income Countries (LMICs): A Systematic Review of Recent Evidence (Gojjam Limenih, Western University)

At the end of this presentation, participants will be able to: 
•    Describe the major categories of non-pharmacological interventions used to support adults with severe mental illness in low- and middle-income countries.
•    Summarize the evidence regarding the effectiveness of non-pharmacological interventions in improving clinical, functional, and socioeconomic outcomes among people with severe mental illness in LMICs.
•    Identify key considerations for implementing culturally adapted and integrated non-pharmacological interventions for severe mental illness in resource-constrained settings.

11:35 to 11:45 am - Question and Answer Period

11:45 am-12:05 pm    
Cumulative Trauma and Alcohol Use Among War Survivors in El Salvador: A Community Based Study (Fernando Chacon, Western University)

At the end of this presentation, participants will be able to: 
•    Describe lifetime trauma exposure and alcohol use patterns among Salvadoran Civil War survivors.
•    Discuss the complexity between cumulative trauma and alcohol use in war-affected populations, including the effects of gender roles and cultural factors.
•    Identify considerations for designing culturally informed addiction services in populations affected by violence and structural adversity.

12:05 to 12:15 pm - Question and Answer Period

Theme: Advancing Military and Veteran Mental Health Care (Room: Regency B)


11:15 to 11:35 am    
From Guidelines to Reality: Understanding Benzodiazepine Prescribing in Specialized PTSD Care (Jenny JW Liu, Western University)

At the end of this presentation, participants will be able to: 
•    Describe patterns of benzodiazepine prescribing in Canadian military and Veteran populations receiving specialized PTSD care.
•    Interpret findings in the context of guideline recommendations and real-world clinical complexity.
•    Recognize the need for nuanced, practice-informed approaches to benzodiazepine use in PTSD.

11:35 to 11:45 am - Question and Answer Period

11:45 am to 12:05 pm
Twenty-Five Years of Measurement-Based Care in Canada: Lessons from Clinical Practice, Research, and National Data Infrastructure in Veteran Mental Health (J. Don Richardson, Western University)

At the end of this presentation, participants will be able to: 
•    Describe how 25 years of measurement-based care within Canadian OSI clinics has contributed to a learning health system for Veteran mental health.
•    Identify how longitudinal clinical measurement can reveal patterns in comorbidity, functional impairment, suicide risk, treatment response, and recovery.
•    Discuss how measurement infrastructure, integrated data, emerging analytics, and clinician researcher partnerships can inform person-centred care, research priorities, and mental health policy.

12:05 to 12:15 pm - Question and Answer Period

Theme: Substance Exposure and the Brain (Room: Regency C)

11:15 to 11:35am    
Omega-3 Supplementation Protects Against the Persistent Behavioural and Neuronal Effects of Adolescent THC Exposure (Marieka DeVuono, Western University)

At the end of this presentation, participants will be able to: 
•    Describe how adolescent THC exposure disrupts neurodevelopment to produce lasting, sex-specific deficits in memory and emotional behaviour, using evidence from a translational rodent model.
•    Explain the rationale for omega-3 fatty acids as a protective intervention, based on their roles in neurodevelopment, endocannabinoid signalling, and inflammation.
•    Evaluate how preclinical evidence supports omega-3 supplementation as a feasible, clinically translatable harm-reduction strategy for adolescent cannabis use.

11:35 to 11:45 am - Question and Answer Period

11:45 am to 12:05pm    
A Seed-Based Resting State fMRI Functional Connectivity Study of the Nuclei Basalis of Meynert in Adults with a History of Adolescent Nicotine Exposure and Current Depression/Anxiety Symptoms (Victor Issa-Garcia, Western University)

At the end of this presentation, participants will be able to: 
•    Describe studies relating adolescent nicotine exposure to adult depression/anxiety.
•    Explain the hypothesis involving the nuclei basalis of Meynert in nicotine-induced depression/anxiety.
•    Describe what seed-based functional connectivity in resting state fMRI is.

12:05 to 12:15 pm - Question and Answer Period

Theme: Advances in Monitoring and Management in Serious Mental Illness (Room: Crystal Ballroom)


11:15 to 11:35 am    
Non-Pharmacological Approaches for Violence in Inpatient Psychiatric Settings, a Systematic Review (Mebaa Kassa, Western University)

At the end of this presentation, participants will be able to: 
•    Describe current research trends in non-pharmacological interventions to reduce violence and aggression in inpatient psychiatric settings.
•    Compare the main categories of non-pharmacological interventions studied in inpatient psychiatry, including staff training, patient-focused therapies, sensory/music-based approaches, and multimodal programs.
•    Identify key methodological limitations in the current evidence base and areas for future research on violence reduction in inpatient psychiatric care.

11:35 to 11:45 am - Question and Answer Period

Concurrent Session B

Concurrent Session B

Theme: EEG Insights into Meditation (Room: Regency A)


1:30 to 1:50 pm    
Binaural Beats and the Brain: EEG and Self-Report Response to 10 Hz Binaural Beat Meditation in Young Adults (Cheyenne Morris, Western University)

At the end of this presentation, participants will be able to: 
•    Describe the efficacy of using a sound-based neuromodulation technique in conjunction with mindfulness meditation as an accessible, low-cost adjunct to treatment.
•    Describe the importance of taking pre-existing posttraumatic symptoms into consideration when recommending or utilizing meditation-related practices.
•    Discuss how integrating low-cost, accessible treatments (such as binaural beats and mindfulness meditation) into practice can enhance accessible mental health and addiction treatment.

1:50 to 2 pm - Question and Answer Period

2 to 2:20pm    
Meditating in Virtual Reality: EEG Insights (Alexa Van Rassel, Western University)

At the end of this presentation, participants will be able to: 
•    Describe the application of virtual reality (VR) meditation as a mental health intervention.
•    Describe meditation-related adverse effects (MRAE) and the caution required to practice meditation with posttraumatic stress symptoms.
•    Describe the brain bases of virtual reality meditation.

2:20 to 2:30 pm - Question and Answer Period

Theme: Decoding the Epigenomics of Sexual Behaviour Disorders (Room: Regency B)

1:30 to 1:50 pm    
Problematic Sexual Behaviour and Psychiatric Comorbidity: Insights from a Genome-Wide Association Study (Rohit Lodhi, Western University)

At the end of this presentation, participants will be able to: 
•    Describe the concept and clinical features of problematic sexual behaviour.
•    Interpret the results of a genome-wide association study of problematic sexual behaviour.
•    Identify the role of concurrent psychiatric disorders and conditions in problematic sexual behaviour.

1:50 to 2 pm - Question and Answer Period

2 to 2:20 pm    
Distinct Epigenomic Profiles in Individuals with Compulsive Sexual Behaviour Disorder (Marco De Tubino Scanavino, Western University)

At the end of this presentation, participants will be able to: 
•    Recognize emerging biological and epigenetic correlates of Compulsive Sexual Behavior Disorder (CSBD).
•    Evaluate the significance of genome-wide DNA methylation alterations identified in individuals with CSBD compared with healthy controls.
•    Discuss how epigenetic research may contribute to the development of future biomarkers, preventive strategies, and therapeutic approaches for CSBD.

2:20 to 2:30 pm - Question and Answer Period

Theme: Advancing Harm Reduction in Health Care (Room: Regency C)

1:30 to 1:50 pm    
Identifying Harm Reduction Practices, Barriers and Facilitators Among Staff Across Four Hospital Sites in London, ON (Cheryl Forchuk, Western University)

At the end of this presentation, participants will be able to: 
•    Describe cultural shifts in organizational attitudes toward substance use and stigma.
•    Identify the facilitators and barriers to implementing harm reduction strategies into various hospital settings
•    Describe the differences between different types of hospitals and approaches to harm reduction.

1:50 to 2 pm - Question and Answer Period

2 to 2:20 pm    
Bridging the Gap: Canadian Healthcare Providers’ Perspectives of Harm Reduction and Substance Use Education in Hospital (Leanne Scott, Western University)

At the end of this presentation, participants will be able to: 
•    Describe desired improvements identified by health care providers, including enhanced education, resource development, policy change, and culture shift and explain how these changes support optimal care for people who use unregulated substances.
•    Apply study insights to propose evidence informed strategies for improving hospital culture, supporting policy development, and guiding future harm reduction education and research.
•    Describe the hospital context surrounding unregulated substance use, including the complexity of patient needs and the challenges health care providers face in delivering supportive care.

2:20 to 2:30 pm - Question and Answer Period

Concurrent Session C

Concurrent Session C

Theme: Military Mental Health Prevention and Treatment (Room: Regency A)

2:45 to 3:05 pm
Toward a Multi-Level Prevention Framework for Moral Injury in Military and Other High Risk Occupational Contexts (Anthony Nazarov, Western University)

At the end of this presentation, participants will be able to: 
•    Describe current gaps in the literature on the prevention of moral injury in military another high-risk occupational contexts.
•    Identify prevention targets across individual, organizational, and systemic levels, as well as across different phases of exposure.
•    Examine a preliminary multi-level framework for the prevention of moral injury.

3:05 to 3:15 pm - Question and Answer Period

3:15 to 3:35pm    
From Consensus to Practice: Co-Developing Treatment Guidance for Canadian Military and Veterans (Jenny JW Liu, Western University)

At the end of this presentation, participants will be able to: 
•    Describe key consensus priorities identified through a Canadian national modified Delphi on the treatment of military-related PTSD.
•    Identify clinical, family, organizational, and policy factors that influence implementation of treatment guidance.
•    Apply co-development principles to translate consensus into actionable clinical guidance and coordinated implementation across Canadian military and Veteran systems.

3:35 to 3:45 pm - Question and Answer Period

Theme: Substance Use, Mental Health and Homelessness (Room: Regency B)

2:45 to 3:05 pm    
Substance Use, Quality of Life, and Homelessness: A Comparative Study of Women Veterans and Women Experiencing Homelessness in Canada (Nikita Burman, Western University)

At the end of this presentation, participants will be able to: 
•    Describe substance use and quality of life differences between women Veterans and the general women homeless population.
•    Identify quality of life differences (particularly emotional well-being, living situation, and finances) between these two groups of women with lived experience of homelessness.
•    Discuss implications for the development of gender-specific addiction care models for women experiencing homelessness, including Veterans.

3:05 to 3:15 pm - Question and Answer Period

3:15 to 3:35 pm    
“I probably would’ve committed suicide if I wasn’t high”: An Ecological Perspective on Hopelessness Among Unhoused Persons Who Use Methamphetamine (Siana Shemshedini, Western University)

At the end of this presentation, participants will be able to: 
•    Describe the experiences of hopelessness among persons experiencing homelessness who use methamphetamine.
•    Recognize how factors across Bronfenbrenner's ecological systems influence the experience of hopelessness among unhoused persons who use methamphetamine.
•    Discuss the implications of these findings for the development of supports to mitigate hopelessness and improve mental well-being among unhoused persons who use methamphetamine.

3:35 to 3:45 pm - Question and Answer Period

Theme: Depression (Room: Regency C)

2:45 to 3:05 pm    
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) as an Anti-Inflammatory Strategy for the Treatment of Depression (Joy Jiang, Western University)

At the end of this presentation, participants will be able to: 
•    Describe the role of the vagus nerve in regulating inflammation and its relevance to neuroimmune health.
•    Describe the proposed biological pathways through which taVNS exerts its anti-inflammatory effects.
•    Discuss how reducing inflammation may contribute to the improvement of depression symptoms.

3:05 to 3:15 pm - Question and Answer Period

3:15 to 3:35pm    
Impaired in Life: Analyzing People’s Accounts of Depression in Ethiopia: Implications for a Cultural-Eco Social Approach to Global Mental Health (Gojjam Limenih, Western University)

At the end of this presentation, participants will be able to: 
•    Explain how depression should be viewed beyond narrow biomedical interpretations and understood within broader sociocultural, economic, and spiritual contexts that shape lived experiences of distress.
•    Explain how illness narratives of depression reflect the interaction between individual suffering, social expectations, and broader structural determinants in Ethiopia.
•    Explain how depression is tied to sociocultural, economic, and spiritual contexts in shaping patients' lived experiences and meanings of distress in Northern Ethiopia.

3:35 to 3:45 pm - Question and Answer Period

Theme: Spiritual Employee Mental Health (Room: Crystal Ballroom)

2:45 to 3:05 pm    
The Spirituality of Leadership in Occupational Therapy (Clark Heard, Western University)

At the end of this presentation, participants will be able to: 
•    Describe and/or apply a practical definition of spirituality.
•    Consider the implications of spirituality for Occupational Therapy leadership participation.
•    Consider the impacts of spirituality on occupational engagement, well-being, and leadership practice.

3:05 to 3:15 pm - Question and Answer Period

Location & Details

Location: Best Western Plus Lamplighter Inn & Conference Centre 591 Wellington Rd, London, ON N6C 4R3

Other Upcoming Events

Closing the Loop on Pain: Innovating for Better Recovery

Learn more
From Panic to Power: Rewriting the asthma story

From Panic to Power: Rewriting the asthma story

Learn more